The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.
Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach
Open accessAbstract
Abstract Numerous studies have engineered nanoparticles with different physicochemical properties to enhance the delivery efficiency to solid tumors, yet the mean and median delivery efficiencies are only 1.48% and 0.70% of the injected dose (%ID), respectively, according to a study using a nonphysiologically based modeling approach based on published data from 2005 to 2015. In this study, we used physiologically based pharmacokinetic (PBPK) models to analyze 376 data sets covering a wide range of nanomedicines published from 2005 to 2018 and found mean and median delivery efficiencies at the last sampling time point of 2.23% and 0.76%ID, respectively. Also, the mean and median delivery efficiencies were 2.24% and 0.76%ID at 24 h and were decreased to 1.23% and 0.35%ID at 168 h, respectively, after intravenous administration. While these delivery efficiencies appear to be higher than previous findings, they are still quite low and represent a critical barrier in the clinical translation of nanomedicines. We explored the potential causes of this poor delivery efficiency using the more mechanistic PBPK perspective applied to a subset of gold nanoparticles and found that low delivery efficiency was associated with low distribution and permeability coefficients at the tumor site (P < 0.01). We also demonstrate how PBPK modeling and simulation can be used as an effective tool to investigate tumor delivery efficiency of nanomedicines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–236 of 236
Cabazitaxel-conjugated nanoparticles for docetaxel-resistant and bone metastatic prostate cancer
Hoang, B., Ernsting, M. J., Tang, W.-H. S., Bteich, J., Undzys, E., Kiyota, T., & Li, S. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.029 · Cited by 44
Sumitani, S., Oishi, M., & Nagasaki, Y. (2011) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2011.03.010 · Cited by 43
Roy, A., Zhao, Y., Yang, Y., Szeitz, A. J., Klassen, T., & Li, S. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.05.019 · Cited by 43
Boissenot, T., Bordat, A., Larrat, B., Varna, M., Chacun, H., Paci, A., Poinsignon, V., Fattal, E., & Tsapis, N. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.041 · Cited by 41
Hong, J., Liu, Y., Xiao, Y., Yang, X., Su, W., Zhang, M., Liao, Y., Kuang, H., & Wang, X. (2017) · Drug Delivery · doi:10.1080/10717544.2016.1233589 · Cited by 40
Targeting B16 tumors in vivo with peptide-conjugated gold nanoparticles
Poon, W., Zhang, X., Bekah, D., Teodoro, J. G., & Nadeau, J. (2015) · Nanotechnology · doi:10.1088/0957-4484/26/28/285101 · Cited by 39
Tomalová, B., Šírová, M., Rossmann, P., Pola, R., Strohalm, J., Chytil, P., Černý, V., Tomala, J., Kabešová, M., Říhová, B., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.023 · Cited by 39
Cheng, Y., Riviere, J. E., Monteiro-Riviere, N. A., & Lin, Z. (2018) · Nanotoxicology · doi:10.1080/17435390.2018.1459922 · Cited by 39
Self-citationYao, X., Xie, C., Chen, W., Yang, C., Wu, W., & Jiang, X. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00479 · Cited by 38
Negi, L. M. S., Talegaonkar, S., Jaggi, M., Verma, A. K., Verma, R., Dobhal, S., & Kumar, V. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.09.061 · Cited by 37
Evaluation of a PSMA-targeted BNF nanoparticle construct
Azad, B. B., Banerjee, S. R., Pullambhatla, M., Lacerda, S. H. D. P., Foss, C. A., Wang, Y., Ivkov, R., & Pomper, M. G. (2015) · Nanoscale · doi:10.1039/c4nr06069e · Cited by 36
A Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy
Shi, J., Wang, B., Chen, Z., Liu, W., Pan, J., Hou, L., & Zhang, Z. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1891-7 · Cited by 36
Dai, Y., Xing, H., Song, F., Yang, Y., Qiu, Z., Lu, X., Liu, Q., Ren, S., Chen, X., & Li, N. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.03.038 · Cited by 35
Deng, H., Zhao, X., Deng, L., Liu, J., & Dong, A. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.002 · Cited by 33
Zhang, Z., Wan, J., Sun, L., Li, Y., Guo, J., & Wang, C. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.035 · Cited by 31
“Nano-Ginseng” for Enhanced Cytotoxicity AGAINST Cancer Cells
Dai, L., Zhu, W., Si, C., & Lei, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020627 · Cited by 31
Huang, H., Yue, T., Xu, K., Golzarian, J., Yu, J., & Huang, J. T. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.04.047 · Cited by 30
Huang, P., Liu, J., Wang, W., Zhang, Y., Zhao, F., Kong, D., Liu, J., & Dong, A. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.11.038 · Cited by 30
Li, L., Wang, X., Li, X., Yang, Y., Yue, X., Zhang, Q., & Dai, Z. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00508 · Cited by 28
89Zr‐ and Fe‐Labeled Polymeric Micelles for Dual Modality PET and T1‐Weighted MR Imaging
Starmans, L. W. E., Hummelink, M. A. P. M., Rossin, R., Kneepkens, E., Lamerichs, R. M. J. N., Donato, K., Nicolay, K., & Grüll, H. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500414 · Cited by 27
Hou, J., Guo, C., Shi, Y., Liu, E., Dong, W., Yu, B., Liu, S., & Gong, J. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.09.058 · Cited by 27
Sadekar, S., Linares, O., Noh, G., Hubbard, D., Ray, A., Janat-Amsbury, M.-M., Peterson, C. M., Facelli, J. C., & Ghandehari, H. (2012) · Drug Delivery and Translational Research · doi:10.1007/s13346-012-0119-6 · Cited by 26
Tumor Selective Silencing Using an RNAi-Conjugated Polymeric Nanopharmaceutical
Svenson, S., Case, R. I., Cole, R. O., Hwang, J., Kabir, S. R., Lazarus, D. D., Soo, P. L., Ng, P., Peters, C., Shum, P., et al. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00608 · Cited by 26
Wong, A. W., Ormsby, E. L., Zhang, H., Seo, J. W., Mahakian, L. M., Caskey, C. F., & Ferrara, K. W. (2013) · PubMed Central · Cited by 25
Oh, Y., Swierczewska, M., Kim, T. H., Lim, S. M., Eom, H., Park, J. H., Na, D. H., Kim, K., Lee, K. C., Pomper, M. G., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.014 · Cited by 24
Riviere, J. E., Scoglio, C., Sahneh, F. D., & Monteiro-Riviere, N. A. (2013) · Computational Science & Discovery · doi:10.1088/1749-4699/6/1/014005 · Cited by 23
Self-citationZhang, L., Liu, F., Li, G., Zhou, Y., & Yang, Y. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24649 · Cited by 23
Guo, Y., Zhao, Y., Wang, T., Li, R., Han, M., Dong, Z., Zhu, C., & Wang, X. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00536 · Cited by 21
Yan, C., Gu, J., Daping, H., Jing, H., Wang, J., Guo, Y., Katsumi, H., Sakane, T., & Yamamoto, A. (2014) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2014.891127 · Cited by 19
Chen, R., Zhang, Y., Monteiro‐Riviere, N. A., et al. (2016) · Nanotoxicology · doi:10.1080/17435390.2016.1177745 · Cited by 19
Self-citationMathematical modeling of the heterogeneous distributions of nanomedicines in solid tumors
He, H., Liu, C., Liu, Y., Liu, X., Wu, Y., Fan, J., Zhao, L. Y., & Cao, Y. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.06.005 · Cited by 15
WenPing, Z., Sun, J., Fang, W.-H., Ai, X., Cai, C., Tang, Y., Su, X., Zhi, F., Liu, Y., Tao, M., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.10.007 · Cited by 14
Tian, B., Zhang, X., Yu, C., Zhou, M., & Zhang, X. (2015) · Nanoscale · doi:10.1039/c4nr06743f · Cited by 13
Gao, Z., Nakanishi, Y., Noda, S., Omachi, H., Shinohara, H., Kimura, H., & Nagasaki, Y. (2017) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2017.1288774 · Cited by 11
Du, L., Zhang, B., Lei, Y., Wang, S., & Jin, Y. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.02.024 · Cited by 10
Allen, C. J., & Park, K. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.024 · Cited by 4
Cited by
Conquering the Hypoxia Limitation for Photodynamic Therapy
Wan, Y., Fu, L., Li, C., Lin, J., & Huang, P. (2021) · Advanced Materials · doi:10.1002/adma.202103978 · Cited by 705
Non-viral vectors for RNA delivery
Yan, Y., Liu, X.-Y., Lu, A., Wang, X.-Y., Jiang, L.-X., & Wang, J.-C. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.008 · Cited by 332
Controlling the biodistribution and clearance of nanomedicines
Cabral, H., Li, J., Miyata, K., & Kataoka, K. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00138-1 · Cited by 303
Targeted liposomal drug delivery: a nanoscience and biophysical perspective
Liu, Y., Castro Bravo, K. M., & Liu, J. (2021) · Nanoscale Horizons · doi:10.1039/d0nh00605j · Cited by 294
Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery
Waheed, S., Li, Z., Zhang, F., Chiarini, A., Armato, U., & Wu, J. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01605-4 · Cited by 259
Metadata
- Authors
- Cheng, Y.-H., He, C., Riviere, J. E., Monteiro-Riviere, N. A., & Lin, Z.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-02-20
- Volume
- 14
- Issue
- 3
- Pages
- 3075-3095
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W3006987776
- Cited by
- 362
- References
- 236
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.